Regeneron Pharmaceuticals
REGN
#293
Rank
ยฃ58.68 B
Marketcap
ยฃ553.67
Share price
1.96%
Change (1 day)
2.50%
Change (1 year)

Regeneron Pharmaceuticals (REGN) Fails to deliver data

Key failure to deliver metrics for Regeneron Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regeneron Pharmaceuticals (REGN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regeneron Pharmaceuticals (REGN) - since 2013

Volume in USD (price x number of shares), data since 2013

Regeneron Pharmaceuticals (REGN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026ยฃ0 M-100%
2025ยฃ69.45 M-20.85%
2024ยฃ87.75 M-26.52%
2023ยฃ0.11 B-5.6%
2022ยฃ0.12 B-53.05%
2021ยฃ0.26 B5.23%
2020ยฃ0.25 B414.86%
2019ยฃ49.73 M-31.98%
2018ยฃ73.11 M69.52%
2017ยฃ43.12 M-78.72%
2016ยฃ0.20 B3.03%
2015ยฃ0.19 B-15.29%
2014ยฃ0.23 B419.89%
2013ยฃ44.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
ยฃ24.94 Mยฃ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ93.01 Mยฃ0.15 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
ยฃ0.20 Bยฃ0.37 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ10.89 Mยฃ69.64 M๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ3.4 Mยฃ75.76 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ9.93 Mยฃ38.5 M๐Ÿ‡บ๐Ÿ‡ธ USA